Magnesium Sulfate Kalceks (Magnesium Sulfate Heptahydrate)

Magnesium sulfate releases magnesium ions that act as calcium antagonists, stabilising neuronal membranes, reducing neuromuscular transmission, causing vasodilation, and relaxing smooth muscle. These actions provide anticonvulsant, anti‑arrhythmic, and bronchodilatory effects.

The dose of Magnesium Sulfate Kalceks is determined by the prescribing clinician based on the specific indication, patient weight, renal function and serum magnesium levels. Only a qualified health professional should set the dosing regimen.

Magnesium sulfate is commonly used in pregnancy for conditions such as eclampsia, but safety depends on clinical judgment. Information on breastfeeding is limited; clinicians should weigh potential benefits against risks and consider alternative therapies when appropriate.

To order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if needed) and import documentation.

Magnesium Sulfate Kalceks is an injectable magnesium salt, offering rapid serum level correction compared with oral magnesium salts that have slower absorption. It is preferred in acute settings such as eclampsia or severe arrhythmias where immediate therapeutic effect is required.

The product should be stored at controlled room temperature, kept in its original packaging, protected from light and moisture, and inspected for particulate matter before use. Do not freeze or expose to extreme temperatures.

Magnesium Sulfate Kalceks is administered by intramuscular or intravenous injection under the supervision of a qualified health professional. The route, rate and duration are determined by the clinical indication and patient response.

Serious risks include respiratory depression, severe hypotension, cardiac arrhythmias such as heart block, hypermagnesemia leading to neurological impairment, and rare anaphylactic reactions. Continuous monitoring of vital signs and serum magnesium is essential during therapy.

Patients with known hypersensitivity to magnesium sulfate, existing heart block, severe renal failure, or uncontrolled myasthenia gravis should generally avoid this medication unless the benefits outweigh the risks and close monitoring is possible.